Malaria Rapid Diagnostic Test
Malaria RDT· also: MP RDT, Malaria Antigen, Malaria test
Clinical Overview
Malaria Rapid Diagnostic Test (RDT) detects Plasmodium antigens in a finger-prick blood sample within 15–20 minutes. Most malaria RDTs detect HRP-2 (histidine-rich protein 2) specific to Plasmodium falciparum — the most dangerous malaria species — and/or pLDH (parasite lactate dehydrogenase) which detects P. vivax, P. malariae, and P. ovale. RDTs have replaced microscopy in many endemic areas due to speed, ease of use, and not requiring laboratory infrastructure.
Why This Test Matters
Malaria kills over 600,000 people per year — predominantly children under 5 in sub-Saharan Africa. P. falciparum causes the most severe disease: cerebral malaria, severe anemia, acute respiratory distress syndrome, and multi-organ failure. P. vivax and P. ovale form dormant liver stages (hypnozoites) that can cause relapse months to years later — requiring additional treatment with primaquine or tafenoquine to prevent relapse. The key limitation of RDTs: a positive HRP-2 test can persist for 2–4 weeks after successful treatment (as the HRP-2 antigen is cleared more slowly than viable parasites). For treatment monitoring and cure confirmation, thick blood smear microscopy or PCR is needed. Also, deletion of the HRP-2 gene in some P. falciparum strains (reported in South America and increasingly in Africa) causes false-negative RDTs — use pLDH-based tests in areas with known HRP-2 deletion.
Reference RangesWHO/IFCC standards
| Reference Range | Unit | Notes |
|---|---|---|
| Negative / Non-reactive | qualitative | Negative = no malaria antigen detected |
What Causes Abnormal Results?
High Malaria RDT Causes
- P. falciparum malaria (most common in sub-Saharan Africa)
- P. vivax malaria (most common in South Asia, Southeast Asia, Latin America)
- P. malariae, P. ovale (less common)
- P. knowlesi (zoonotic malaria from macaques — Southeast Asia)
- Transmitted by Anopheles mosquito bites at dusk and dawn
Low Malaria RDT Causes
- Negative RDT does not completely exclude malaria — sensitivity is lower at very low parasite densities
- HRP-2 gene deletion in some P. falciparum strains causes false-negative results
- Prozone effect (very high parasite density can occasionally cause false-negative HRP-2 tests)
Signs & Symptoms to Watch For
How to Prepare for This Test
No fasting required. Blood sample is typically obtained by finger-prick (capillary blood). RDTs can be performed at point-of-care in endemic settings without laboratory infrastructure. For travel returnees, ensure the clinician knows the travel itinerary — malaria species prevalence varies by region. If RDT is negative but malaria is clinically suspected, always confirm with thick and thin blood film microscopy and/or PCR.
Factors That Can Affect Results
- HRP-2 gene deletion in P. falciparum (increasingly common in parts of Amazonia and Horn of Africa) — causes false-negative HRP-2-based RDT
- Residual HRP-2 antigenemia after successful treatment (can remain positive for 2–4 weeks post-treatment)
- Prozone effect at extremely high parasitemia (rare false negative)
- Rheumatoid factor can cause false-positive malaria RDTs in some test systems
- Prolonged storage or exposure to high temperatures degrades RDT reagents
Related Topics
Frequently Asked Questions
My malaria RDT was negative but I just returned from Africa with a high fever — could I still have malaria?
Yes — a negative RDT does not completely exclude malaria, especially if: you have very low parasite density (early infection), you are infected with a strain carrying HRP-2 gene deletions (increasingly common in parts of Africa), or your exposure history is compelling. You must have thick and thin blood film microscopy performed immediately. If the first blood smear is negative and suspicion remains high, repeat smears should be performed every 12–24 hours for 3 days, as parasite density fluctuates with the fever cycle. Malaria can be fatal if not treated — clinical suspicion overrides a negative RDT when travel history is consistent.
What is the difference between falciparum malaria and vivax malaria?
P. falciparum is the deadliest species — it causes severe malaria through adherence of parasitized red cells to brain blood vessels (cerebral malaria) and can kill within 24–48 hours without treatment. P. falciparum has no dormant liver stage, so treatment with artemisinin-based combination therapy (ACT) is curative. P. vivax is less immediately life-threatening but forms dormant liver stages (hypnozoites) that cause relapse months or years later. P. vivax treatment requires chloroquine PLUS primaquine (or tafenoquine) to eliminate the liver reservoir. G6PD deficiency must be tested before giving primaquine as it can cause hemolysis.